Drugs Made In America Acquisition II Corp. Ordinary Shares
- DMII
- NASDAQ
- Financial - Conglomerates
- SPAC/Blank Check Company
- Merger/Acquisition Vehicle
$10.19
Today +0.10%Quote Oct 20, 2026, 08:00 PM UTC
Limited analysis: bank-specific metrics are not in this version yet. Debt, free-cash-flow and generic valuation ratios are hidden for this company.
+0.10%over the last month
Max drawdown −0.2%From 1-month high −0.1%3 months +1.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Drugs Made In America Acquisition II Corp. Ordinary Shares
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities.
Sector
Financial services
Industry
Financial - Conglomerates
Exchange
NASDAQ
Employees
2
Founded
2024
Market value
$648.8M
Quote Oct 20
Floor
$10.17
0.1% below price
Resistance
$10.15
Price is above this level
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about DMIIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free